2026 NPPES data Optometrist NPI 1689916520
Verify on CMS →

Mark Emmanuel Landig

Optometrist in Los Angeles, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
670
Medicare Part D claims · 303 beneficiaries · Optometrist avg: 257
Generic prescribing
45%
generic claims · 55% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
74.6/100
▼ 9 pts below national avg 83.1 · [object Object]
Industry payments
$89.05
4 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

Mark Emmanuel Landig reported a CMS MIPS final score of 74.6/100 — below the 83.1 national average — and filed 670 Medicare Part D claims in 2023.

74.6/100
MIPS score · -9 vs avg
670
Part D claims, 2023
45%
generic prescribing
$89.05
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

Mark Emmanuel Landig's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

75 12th percentile higher than 12% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). This entry sits in this band. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

What does the federal data show about Mark Emmanuel Landig?

Below national average

NPI registry status

Active

Issued 03/18/2013

NPI 1689916520

Primary specialty

Optometrist

High-volume

60,463 US NPIs in this specialty

Medicare Part D claims

670 161% vs specialty avg

2023 prescription claims

Specialty avg: 257

MIPS final score

74.6/100 8.5 pts vs avg

Mid-tier band

vs 83.1 national avg

Specialty distribution in California

How Optometrist compares to other specialties among California providers

California providers

Optometrist share within California

1. Optometrist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Optometrist share within California

Medicare quality performance — MIPS

Mark Emmanuel Landig's 2023 MIPS final score plotted against the Optometrist national average

Below national average
MIPS Final Score
74.6/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Optometrist) — 74.6/100 vs national avg 83.1

0%100%National avg83%74.6%
MIPS final score (Optometrist) — 74.6/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Mark Emmanuel Landig appears in the CMS NPPES registry as a Optometrist provider at 300 STEIN PLAZA, Los Angeles, CA, 90095, with a listed phone of (310) 825-5000. NPI 1689916520 was issued on 03/18/2013. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what Landig most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 670 prescription claims written by this provider, covering 303 Medicare beneficiaries and totaling roughly $227K in drug spend, split 55% brand-name and 45% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 74.6/100 for the 2023 performance year (Quality 85, Cost 30.2), compared with the national average of 83.1.

Optometrist is a high-volume specialty nationwide, with 60,463 enrolled providers across 56 states and an average of 257 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

300 STEIN PLAZA
Los Angeles, CA 90095

Provider Details

NPI 1689916520
Specialty Optometrist
Gender Male
NPI Issued 03/18/2013

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

74.5602
Final Score
Avg: 83.1
85.0247
Quality
30.176
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where Mark Emmanuel Landig bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

Jules Stein Eye Institute Medical Group
Los Angeles, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Mark Emmanuel Landig. Source: openpaymentsdata.cms.gov.

Total received

$89

Largest payer

SUN PHARMACEUTICAL INDUSTRIES INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to Mark Emmanuel Landig. To verify Mark Emmanuel Landig's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

Mark Emmanuel Landig — brand share 55.0%
Specialty average (est.)

55% brand-name claims vs 45% generic, on 670 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

670
Total Claims
$227K
Total Drug Cost
303
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
958
Total Day Supply
27,070
Brand vs Generic
55% brand / 45% generic
Brand Drug Cost
$200K
Generic Drug Cost
$27K

Patient Demographics

Average Patient Age
77.5 years
Avg HCC Risk Score
1.28
Gender Split
60% female / 40% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What Mark Emmanuel Landig prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Difluprednate
157
Latanoprost
132
Prednisolone Acetate
95
Xiidra
Lifitegrast
71
Restasis
Cyclosporine
59
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
24
Cyclosporine
22
Lumigan
Bimatoprost
18
Timolol Maleate
18

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Optometrist Overview

How Mark Emmanuel Landig fits within the Optometrist landscape nationally.

60,463
Optometrist Providers in US
56
States with Optometrist
257
Avg Claims per Provider

Mark Emmanuel Landig's 670 claims are above the specialty average of 257.

Nearby Optometrist Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Landig.

Compare Optometrist nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry — providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the California medical board — federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Optometrist peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only — they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Mark Emmanuel Landig's specialty?
Mark Emmanuel Landig specializes in Optometrist and practices in Los Angeles, California.
How much does Mark Emmanuel Landig prescribe under Medicare Part D?
In 2023, Mark Emmanuel Landig wrote 670 Medicare Part D claims totaling $227K in drug costs for 303 beneficiaries.
What is Mark Emmanuel Landig's Medicare quality score?
Mark Emmanuel Landig has a CMS MIPS Final Score of 74.6/100 (Quality: 85, Cost: 30.2). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Mark Emmanuel Landig located?
Mark Emmanuel Landig is located at 300 STEIN PLAZA, Los Angeles, CA, 90095. Phone: (310) 825-5000.
What is Mark Emmanuel Landig's NPI number?
Mark Emmanuel Landig's National Provider Identifier (NPI) is 1689916520, issued on 03/18/2013.
Does Mark Emmanuel Landig prescribe more brand-name or generic drugs?
Mark Emmanuel Landig's prescribing is 55% brand-name and 45% generic drugs by claim count, with $200K in brand drug costs.
How many Optometrist providers are there in the US?
There are 60,463 Optometrist providers across 56 states in the US. The average Optometrist provider writes 257 Medicare Part D claims per year.
What drugs does Mark Emmanuel Landig prescribe most often?
Based on 2023 Medicare Part D data, Mark Emmanuel Landig's most frequently prescribed drugs include Difluprednate, Latanoprost, Prednisolone Acetate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Mark Emmanuel Landig accept Medicare?
Mark Emmanuel Landig appears in CMS Medicare data with 670 Part D claims and 303 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Mark Emmanuel Landig's credentials?
Mark Emmanuel Landig's NPI is 1689916520. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology